Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Mesa Laboratories, Inc.NASDAQ: MLAB

EBITDA · Q4 FY2026 · quarter ended Mar 2026

EBITDA dips below year-ago levels

Q4 FY2026 EBITDA of $4.16M fell 60.3% year over year, behind the +4.0% change in trailing-twelve-month EBITDA. Sequentially, it fell 68.9% from the prior quarter. Over 3 fiscal years it compounded at -2.0% a year.

Context

  • EBITDA amounted to 14.2% of revenue in FY2026, down 3.4 pp from a year earlier.
  • EBITDA increased in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of $109.83M (+211.3%) for the fiscal year ending Mar 2027, a step up from the -16.7% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.16M-68.9% QoQ
Last fiscal yearMar 2026
$35.29M-16.7% YoY
LTMMar 2026
$43.38M+4.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-60.3%+79.0%+139.3 pp
1 year-16.7%+211.3%+227.9 pp
3-year CAGR-2.0%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
35.29M USD
Year-over-year change
-16.7%
4-year CAGR
+2.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's LTM Mar 2026 EBITDA of $43.38M is the 7th highest of the 11 companies compared; the peer median is $421.73M.
  • Its year-over-year change of +4.0% is the 7th highest of 11, against a peer median of +9.5%.
  • EBITDA amounts to 17.4% of revenue for MLAB, versus a peer median of 26.7%.
MLAB Competitors Peer median
EBITDA for MLAB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$11.24B -0.8%-1.3%23.7%
AAgilent Technologies, Inc.LTM Jul 2026$2.04B +13.2%-1.2%27.6%
RVTYRevvity, Inc.LTM Jul 2026$767M -6.7%-13.5%26.3%
QGENQiagen N.V.LTM Jun 2026$703.39M -1.6%-2.7%33.5%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$514.7M -22.7%—19.9%
TECHBio-Techne CorporationLTM Sep 2026$328.77M +48.3%-9.1%26.8%
MLABMesa Laboratories, Inc.LTM Mar 2026$43.38M +4.0%-2.0%17.4%
TXG10x Genomics, Inc.LTM Sep 2026$37.56M +221.9%—6.1%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026-$55.57M +77.9%—26.6%
LABStandard BioTools Inc.LTM Mar 2026-$81.51M +5.7%—94.5%
PACBPacific Biosciences of California, Inc.LTM Mar 2026-$106.6M +54.1%—66.6%
Peer median (excluding MLAB) $421.73M+9.5%-2.7%26.7%

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue184.34M219.08M216.19M240.98M249.13M
Cost of Revenue75.25M85.39M82.94M90.11M90.86M
Gross Profit109.09M133.69M133.25M150.87M158.27M
Gross Margin59.2%61.0%61.6%62.6%63.5%
Research & Development15.77M20.49M19.3M19.52M20.31M
Selling, General & Admin88.62M109.88M111.49M115.02M119.45M
Operating Expenses104.39M130.37M405.33M134.53M139.76M
Depreciation & Amortization25.07M33.13M31.57M24.53M23.27M
EBITDA32.53M37.52M(238.38M)42.35M35.29M
EBITDA Margin17.6%17.1%-110.3%17.6%14.2%
Operating Income4.7M3.32M(272.08M)16.34M18.51M
Operating Margin2.6%1.5%-125.9%6.8%7.4%
Interest Income00000
Interest Expense3.89M4.77M5.7M11.86M10.69M
Other Income / Expenses(1.13M)(3.71M)(3.57M)(10.38M)(6.5M)
Income Before Tax3.57M(389K)(275.65M)5.96M12.01M
Pre-Tax Margin1.9%-0.2%-127.5%2.5%4.8%
Income Tax Expense1.7M(1.32M)(21.4M)7.94M5.3M
Net Income1.87M930K(254.25M)(1.97M)6.71M
Net Margin1.0%0.4%-117.6%-0.8%2.7%
EPS (Basic)0.360.17(47.20)(0.36)1.22
EPS (Diluted)0.350.17(47.20)(0.36)1.21
Weighted Avg Shares5.21M5.32M5.39M5.43M5.51M
Weighted Avg Shares (Diluted)5.34M5.36M5.39M5.43M5.57M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.